Why the study?
Does carbon dioxide treatment alter ADP-induced and arachidonate-induced platelet aggregation in human platelet-rich plasma?
Population
Citrated human platelet-rich plasma (PRP)
Comparison
Carbon dioxide (CO2) treatment vs Untreated PRP or PRP subsequently exposed to air
Design
Preclinical
Authors
Loading...
CO2 may differentially modulate platelet aggregation in vitro; leaves open effects on human hemostasis, requiring clinical validation.
Does carbon dioxide treatment alter ADP-induced and arachidonate-induced platelet aggregation in human platelet-rich plasma?
Lowered pH from CO2 exposure increases platelet sensitivity to arachidonate-induced aggregation, which may influence platelet behavior in hemostasis and inflammation.
Kerry et al. (1984) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: